Triple
T22871141
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | pimozide |
E567198
|
entity |
| Predicate | hasPrimaryIndication |
P23161
|
FINISHED |
| Object | Tourette syndrome |
—
|
NE NERFINISHED |
How this triple was built (3 steps)
Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.
NER
Named-entity recognition
gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: Tourette syndrome | Statement: [pimozide, hasPrimaryIndication, Tourette syndrome]
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: Tourette syndrome Context triple: [pimozide, hasPrimaryIndication, Tourette syndrome]
-
A.
Tourette syndrome
chosen
Tourette syndrome is a neurological disorder characterized by involuntary motor and vocal tics, often beginning in childhood and varying in severity over time.
-
B.
Asperger syndrome
Asperger syndrome is a neurodevelopmental condition on the autism spectrum characterized by difficulties in social interaction and communication alongside focused interests and often average or above-average intelligence.
-
C.
Echopraxia
Echopraxia is a hard science fiction novel by Peter Watts that explores transhumanism, consciousness, and post-human evolution in a dark, cerebral future setting.
-
D.
Huntington's chorea
Huntington's chorea is a hereditary neurodegenerative disorder characterized by progressive motor dysfunction, cognitive decline, and psychiatric symptoms, typically manifesting in mid-adulthood.
-
E.
Angelman syndrome
Angelman syndrome is a rare genetic neurodevelopmental disorder characterized by severe intellectual disability, speech impairment, movement and balance problems, and a typically happy, excitable demeanor.
- F. None of above.
- G. Unsure - the case is ambiguous/there is not enough information to decide.
PD
Predicate disambiguation
gpt-5-mini-2025-08-07
Target predicate: hasPrimaryIndication Context triple: [pimozide, hasPrimaryIndication, Tourette syndrome]
-
A.
hasIndication
chosen
Indicates that one entity (typically a product, treatment, or intervention) is intended, approved, or suitable for use in addressing, preventing, or managing a particular condition, purpose, or circumstance.
-
B.
hasPrimary
Indicates that one entity is designated as the main or most important instance (the primary) in relation to another entity.
-
C.
hasPrimaryFeature
Indicates that an entity possesses a main or most characteristic feature that defines or distinguishes it.
-
D.
hasPrimarySee
Indicates that one entity is designated as the main or preferred "see" reference or cross-reference for another entity.
-
E.
hasPrimaryCode
Indicates that an entity is associated with its main or most important identifying code among potentially multiple codes.
- F. None of above.
Provenance (3 batches)
The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.
| Step | Stage | Batch ID | Status | When |
|---|---|---|---|---|
| creating | Elicitation | batch_69e24589d8348190b96422d13a678bc1 |
completed | April 17, 2026, 2:36 p.m. |
| NER | Named-entity recognition | batch_69f17f04b06481909004818ec8fc5a26 |
completed | April 29, 2026, 3:46 a.m. |
| PD | Predicate disambiguation | batch_69eed2d8c0608190afef4c4e530c0e2c |
completed | April 27, 2026, 3:07 a.m. |
Created at: April 17, 2026, 3:38 p.m.